Vbeam Prima
The gold standard in vascular treatments.
Description:
The Vbeam® Prima system: designed to treat rosacea, port wine stains, facial and leg telangiectasia, hemangiomas, angiomas and spider angiomas, deep blue veins and venous lakes, benign pigmented lesions, wrinkles, inflammatory acne vulgaris, scars and benign cutaneous lesions.
Healthcare providers all over the world use the Vbeam Prima system to treat benign vascular, pigmented and cutaneous lesions – for face and body – with high patient tolerability and a low incidence of side effects.
In a clinical study, rosacea symptoms were significantly reduced from moderate to mild after 4 treatments.
- Difficult-to-treat erythema was reduced from severe to mild
- ~90% of patients had >40% rosacea improvement
94%
of patients reported being very satisfied with results
59%
of patients with rosacea weren’t aware of laser therapy as a treatment
50%
Vbeam Prima is 50% more powerful than the previous generation Vbeam Perfecta
80%
of patients treated with the Vbeam were very to extremely satisfied with their results
Rosacea Treatment
- In a clinical study, rosacea symptoms were visibly reduced from moderate to mild
- Difficult-to-treat erythema was reduced from severe to mild
- 84% of patients had >40% rosacea improvement
- Minimal adverse side effects reported
- 94% of patients reported being very satisfied with results
Scars Treatment
- The Vbeam Prima system with the 595 nm wavelength targets the vascular component of scar tissue
- In a clinical study, all scars (100%) treated with the Vbeam 595 nm pulsed dye laser (PDL) showed improvements in cosmesis
- 80% of patients treated with the Vbeam PDL were very to extremely satisfied with their results, and 77% experienced no to moderate pain
- The Vbeam 595 nm pulsed dye laser (PDL) is proven for treating vascular skin lesions and for improving the cosmetic appearance of surgical scars in Fitzpatrick skin types I to IV